JP2014028813A5 - - Google Patents

Download PDF

Info

Publication number
JP2014028813A5
JP2014028813A5 JP2013169253A JP2013169253A JP2014028813A5 JP 2014028813 A5 JP2014028813 A5 JP 2014028813A5 JP 2013169253 A JP2013169253 A JP 2013169253A JP 2013169253 A JP2013169253 A JP 2013169253A JP 2014028813 A5 JP2014028813 A5 JP 2014028813A5
Authority
JP
Japan
Prior art keywords
gln
seq
ala
val
trp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013169253A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014028813A (ja
JP5722966B2 (ja
Filing date
Publication date
Priority claimed from EP06090166A external-priority patent/EP1897885A1/en
Priority claimed from EP07090079A external-priority patent/EP1985624A3/en
Application filed filed Critical
Publication of JP2014028813A publication Critical patent/JP2014028813A/ja
Publication of JP2014028813A5 publication Critical patent/JP2014028813A5/ja
Application granted granted Critical
Publication of JP5722966B2 publication Critical patent/JP5722966B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013169253A 2006-09-08 2013-08-16 18f標識物質のための化合物と方法 Active JP5722966B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP06090166A EP1897885A1 (en) 2006-09-08 2006-09-08 Compounds and methods for F labelled agents
EP06090166.7 2006-09-08
EP07090079A EP1985624A3 (en) 2007-04-23 2007-04-23 Single step method of radiofluorination of biologically active compounds or biomolecules
EP07090079.0 2007-04-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2009527069A Division JP5603074B2 (ja) 2006-09-08 2007-09-07 18f標識物質のための化合物と方法

Publications (3)

Publication Number Publication Date
JP2014028813A JP2014028813A (ja) 2014-02-13
JP2014028813A5 true JP2014028813A5 (enExample) 2014-09-25
JP5722966B2 JP5722966B2 (ja) 2015-05-27

Family

ID=39031005

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009527069A Active JP5603074B2 (ja) 2006-09-08 2007-09-07 18f標識物質のための化合物と方法
JP2013169253A Active JP5722966B2 (ja) 2006-09-08 2013-08-16 18f標識物質のための化合物と方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2009527069A Active JP5603074B2 (ja) 2006-09-08 2007-09-07 18f標識物質のための化合物と方法

Country Status (20)

Country Link
US (1) US8557776B2 (enExample)
EP (5) EP2289564A3 (enExample)
JP (2) JP5603074B2 (enExample)
KR (1) KR20090058553A (enExample)
AR (1) AR062726A1 (enExample)
AU (1) AU2007294124A1 (enExample)
BR (1) BRPI0716554A2 (enExample)
CA (2) CA2662449A1 (enExample)
CL (1) CL2007002620A1 (enExample)
CO (1) CO6150196A2 (enExample)
CR (1) CR10654A (enExample)
IL (4) IL197363A0 (enExample)
MA (1) MA30780B1 (enExample)
MX (1) MX2009002492A (enExample)
NO (1) NO20091428L (enExample)
PE (1) PE20080850A1 (enExample)
RU (1) RU2009112716A (enExample)
TN (1) TN2009000063A1 (enExample)
TW (1) TW200829277A (enExample)
WO (1) WO2008028688A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007294124A1 (en) 2006-09-08 2008-03-13 Bayer Schering Pharma Aktiengesellschaft Compounds and methods for 18F labeled agents
KR20090119966A (ko) * 2007-03-01 2009-11-23 바이엘 쉐링 파마 악티엔게젤샤프트 진단 영상화제로서의 18f 플루오로-벤조일 표지된 생물학적 활성 화합물, 벤조트리아졸-1-일옥시-벤조일, 2,5-디옥소-피롤리딘-1-일옥시)벤조일 및 트리메틸암모니오-벤조일 전구체
GB201013808D0 (en) 2010-08-18 2010-09-29 Ge Healthcare Ltd Peptide radiotracer compositions
WO2012094334A1 (en) * 2011-01-04 2012-07-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services One-step 18f labeling of biological substrates and uses of 18f labeled biological substrates
US20140097078A1 (en) * 2011-06-09 2014-04-10 Ge Healthcare Limited Distillation device and method
EP2970345B1 (en) * 2013-03-15 2019-06-19 Cancer Targeted Technology LLC 18f-labeled psma-targeted pet imaging agents
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
WO2018152339A1 (en) * 2017-02-17 2018-08-23 Yale University Radiolabeled pharmaceuticals and methods of making and using same
SG11202000167SA (en) 2017-07-11 2020-02-27 Synthorx Inc Incorporation of unnatural nucleotides and methods thereof
KR20250145137A (ko) 2017-08-03 2025-10-13 신톡스, 인크. 자가면역 질환의 치료를 위한 사이토카인 접합체
AU2019256714A1 (en) * 2018-04-20 2020-11-12 The General Hospital Corporation Acetylated prodrugs for delivery across the blood-brain barrier
US20200246467A1 (en) 2019-02-06 2020-08-06 Synthorx, Inc. Il-2 conjugates and methods of use thereof
CN113150065B (zh) * 2021-03-11 2022-07-08 武汉英纳氏药业有限公司 一种合成肽及其应用
WO2022246118A2 (en) * 2021-05-20 2022-11-24 The Regents Of The University Of California Pet imaging tracers
EP4692065A1 (en) 2023-03-31 2026-02-11 Nissan Chemical Corporation Pyrazole compound and harmful organism control agent

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723578A (en) * 1987-09-24 1998-03-03 The Administrators Of Tulane Educational Fund Peptide analogs of bombesin
US5084555A (en) 1989-08-21 1992-01-28 The Administrators Of The Tulane Educational Fund An octapeptide bombesin analog
WO1989002897A1 (en) 1987-09-24 1989-04-06 The Administrators Of The Tulane Educational Fund Therapeutic peptides
JP2919889B2 (ja) * 1988-10-14 1999-07-19 アドミニストレイターズ オブ ザ テューレイン エデュケイショナル ファンド 治療用ペプチド
EP0474769B1 (en) * 1989-06-02 1995-11-08 Georgetown University A method for the detection of anti-streptokinase antibodies
US6232071B1 (en) 1990-06-11 2001-05-15 Gilead Sciences, Inc. Tenascin-C nucleic acid ligands
US5244883A (en) 1990-11-29 1993-09-14 The Administrators Of The Tulane Educational Fund Nonapeptide bombesin antagonists
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
BR9814484A (pt) 1997-12-24 2000-10-10 Vertex Pharma "pró-drogas de inibidores de aspartil protease"
WO1999033795A1 (en) 1997-12-24 1999-07-08 Vertex Pharmaceuticals Incorporated Prodrugs of aspartyl protease inhibitors
WO1999033792A2 (en) 1997-12-24 1999-07-08 Vertex Pharmaceuticals Incorporated Prodrugs os aspartyl protease inhibitors
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
US6639076B1 (en) 1998-08-18 2003-10-28 Eli Lilly And Company Growth hormone secretagogues
US6855715B1 (en) 1999-06-14 2005-02-15 Eli Lilly And Company Serine protease inhibitors
WO2002044144A2 (en) 2000-11-30 2002-06-06 Advanced Research And Technology Institute, Inc. Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds
GB0115927D0 (en) * 2001-06-29 2001-08-22 Nycomed Amersham Plc Solid-phase nucleophilic fluorination
GB0206750D0 (en) 2002-03-22 2002-05-01 Amersham Plc Radiofluorination methods
WO2003087069A2 (en) * 2002-04-09 2003-10-23 Eli Lilly And Company Dipeptidic growth hormone secretagogues
ES2299749T3 (es) * 2002-08-09 2008-06-01 Astellas Pharma Europe B.V. Compuestos que se unen a p-selectina.
US20080063599A1 (en) 2002-11-18 2008-03-13 Jorge Setoain Quinquer Compounds Which Can Be Used To Diagnose And Monitor Diseases Associated With The Formation Of Amyloid Protein Fibrils
EP1597270A2 (en) * 2003-02-20 2005-11-23 University of South Florida Peptidomimetic inhibitors of stat3 activity and their medical uses
GB0305704D0 (en) * 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
WO2006083424A2 (en) 2004-12-28 2006-08-10 The Trustees Of Columbia University In The City Of New York Radiolabeled compounds and uses thereof
JP2009505962A (ja) 2005-07-29 2009-02-12 バイエル・ヘルスケア・エルエルシー 肥満を治療するためのビフェニルアミノ酸誘導体の製造および使用
US20080029548A1 (en) 2006-05-05 2008-02-07 Ann De Wree Fabric treatment dispensing package
AU2007294124A1 (en) 2006-09-08 2008-03-13 Bayer Schering Pharma Aktiengesellschaft Compounds and methods for 18F labeled agents

Similar Documents

Publication Publication Date Title
JP2013173781A5 (enExample)
JP2012107057A5 (enExample)
JP2013514381A5 (enExample)
JP2014102408A5 (enExample)
JP2016512050A5 (enExample)
JP2011136981A5 (enExample)
JP2013500200A5 (enExample)
JP2015522045A5 (enExample)
JP2013532130A5 (enExample)
JP2016104015A5 (enExample)
JP2013181136A5 (ja) ポリイミド前駆体組成物、ポリイミド成形体、及び画像形成装置
JP2012094862A5 (enExample)
JP2011037885A5 (enExample)
JP2018509309A5 (enExample)
JP2016516394A5 (enExample)
JP2016200526A5 (enExample)
JP2013531183A5 (enExample)
JP2017528146A5 (enExample)
JP2015174855A5 (enExample)
JP2017019744A5 (enExample)
JP2015047164A5 (enExample)
JP2015030781A5 (enExample)
JP2014508179A5 (enExample)
JP2012050714A5 (enExample)
JP2017533483A5 (enExample)